Druker BJ - Search Results

1

CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.

Wendtner CM, Schmitt B, Gruss HJ, Druker BJ, Emmerich B, Goodwin RG, Hallek M. Wendtner CM, et al. Among authors: druker bj. Cancer Res. 1995 Sep 15;55(18):4157-61. Cancer Res. 1995. PMID: 7545087

2

Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.

Hallek M, Neumann C, Schäffer M, Danhauser-Riedl S, von Bubnoff N, de Vos G, Druker BJ, Yasukawa K, Griffin JD, Emmerich B. Hallek M, et al. Among authors: druker bj. Exp Hematol. 1997 Dec;25(13):1367-77. Exp Hematol. 1997. PMID: 9406996

3

Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells.

Danhauser-Riedl S, Warmuth M, Druker BJ, Emmerich B, Hallek M. Danhauser-Riedl S, et al. Among authors: druker bj. Cancer Res. 1996 Aug 1;56(15):3589-96. Cancer Res. 1996. PMID: 8758931

4

Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase.

Okuda K, Sanghera JS, Pelech SL, Kanakura Y, Hallek M, Griffin JD, Druker BJ. Okuda K, et al. Among authors: druker bj. Blood. 1992 Jun 1;79(11):2880-7. Blood. 1992. PMID: 1375118 Free article.

5

Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.

Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Druker BJ, Lydon NB. Buchdunger E, et al. Among authors: druker bj. Cancer Res. 1996 Jan 1;56(1):100-4. Cancer Res. 1996. PMID: 8548747

6

Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs.

Lim YP, Wong CY, Ooi LL, Druker BJ, Epstein RJ. Lim YP, et al. Among authors: druker bj. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3980-7. doi: 10.1158/1078-0432.CCR-03-0663. Clin Cancer Res. 2004. PMID: 15217928

7

BCR/ABL modulates the cytokine and retinoic acid response of c-Rel in human myeloid cells.

Neumann M, Wilisch A, Ma BC, Druker BJ, Serfling E, Franza BR Jr. Neumann M, et al. Among authors: druker bj. Anticancer Res. 1996 May-Jun;16(3A):1075-83. Anticancer Res. 1996. PMID: 8702216

8

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.

Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ. Heinrich MC, et al. Among authors: druker bj. Blood. 2000 Aug 1;96(3):925-32. Blood. 2000. PMID: 10910906 Free article.

9

Extracellular calcium mimics the actions of platelet-derived growth factor on mouse fibroblasts.

Epstein RJ, Druker BJ, Irminger JC, Jones SD, Roberts TM, Stiles CD. Epstein RJ, et al. Among authors: druker bj. Cell Growth Differ. 1992 Mar;3(3):157-64. Cell Growth Differ. 1992. PMID: 1352989

10

Point mutations in the conserved box 1 region inactivate the human granulocyte colony-stimulating factor receptor for growth signal transduction and tyrosine phosphorylation of p75c-rel.

Avalos BR, Hunter MG, Parker JM, Ceselski SK, Druker BJ, Corey SJ, Mehta VB. Avalos BR, et al. Among authors: druker bj. Blood. 1995 Jun 1;85(11):3117-26. Blood. 1995. PMID: 7538818 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters